FOLR1 and osteosarcoma: Although the exact role of FOLR1 expressed by osteosarcoma is not well elucidated, there is evidence demonstrating uptake of folate by FOLR1 at a lower concentration gradient than reduced folate carrier, the dominant receptor that binds and transports methotrexate, a mainstay in osteosarcoma therapy (18).